Symptoms of Diminished Autonomy over Cigarettes with Non-Daily Use by Savageau, Judith A. et al.
Int. J. Environ. Res. Public Health 2009, 6, 25-35; doi:10.3390/ijerph6010025 
 
International Journal of 
Environmental Research and 
Public Health 
ISSN 1660-4601 
www.mdpi.com/journal/ijerph 
Article 
Symptoms of Diminished Autonomy over Cigarettes with Non-
Daily Use  
Judith A. Savageau 
1, Paul D. Mowery 
2 and Joseph R. DiFranza 
1,*  
1 Department of Family Medicine and Community Health, University of Massachusetts Medical 
School, 55 Lake Avenue, Worcester, Massachusetts 01655, USA; E-Mail: 
judith.savageau@umassmed.edu 
2 Biostatistics, Inc., Atlanta, Georgia, USA; E-mail: moweryp@bellsouth.net 
* Author to whom correspondence should be addressed; Tel.: +1-508-856-5658; Fax: +1-508-856-
1212; E-mail: difranzj@ummhc.org 
Received: 3 November 2008 / Accepted: 20 December 2008 / Published: 23 December 2008 
 
Abstract:  Data from a nationally representative sample of smokers (ages 12-22 years, 
n=2,091) was examined to investigate the prevalence of symptoms of diminished autonomy 
over cigarettes. Six symptoms were assessed: failed cessation, smoking despite a desire to 
quit, and a need or urge to smoke, irritability, restlessness, or disrupted concentration 
attributed to nicotine withdrawal. One or more of the six symptoms were present in 18.9% 
of subjects who smoked less often than once per week. Among subjects who had not 
smoked 20 cigarettes in their lifetime, 12.6% had symptoms of nicotine withdrawal, and 
25% had made an unsuccessful quit attempt. 
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1. Introduction  
Early workers in the field of nicotine addiction believed that a person didn’t become an addicted 
smoker until he or she smoked many cigarettes each day and had smoked for a number of years [1]. 
However, adolescents have complained of difficulties with quitting after smoking only one or two 
cigarettes [2]. To investigate this phenomenon, the Development and Assessment of Nicotine 
Dependence in Youth studies (DANDY-1 and DANDY-2) followed 6
th and 7
th grade students over 
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several years [3-6]. The Diagnostic and Statistical Manual of Mental Disorders (DSM) provides 
criteria that can be used to diagnose “cases” of nicotine dependence, but it does not provide a 
nomenclature to describe smokers who have one or two symptoms of nicotine dependence, but fall shy 
of the three criteria cutoff needed for a diagnosis under the DSM rubric [7]. Therefore, studies of 
smoking onset have only rarely used the DSM criteria [8]. Such studies more commonly assess 
diminished autonomy over tobacco use. As defined, an individual experiences diminished autonomy 
when quitting requires an effort or produces discomfort [9]. It should be noted that the appearance of 
diminished autonomy does not signify a DSM diagnosis of nicotine dependence; but it does represent 
an indication of a process that may progress to a DSM diagnosis of nicotine dependence. 
The 10-symptom Hooked on Nicotine Checklist (HONC) is a validated measure of diminished 
autonomy, currently in use around the world in 14 languages [9, 10]. In the DANDY studies, each of 
the following 10 HONC symptoms was reported by at least one subject within two weeks of smoking 
at least once per month: strong need, urge or craving to smoke, difficulty refraining from smoking, 
feeling addicted, and anxiety, restlessness, irritability, and difficulty concentrating attributed by the 
subject to abstinence from tobacco. Each symptom was reported by some youth who had never been 
daily smokers [5]. Among the subjects who developed these symptoms, 10% had done so within 2 
days, and 25% within 30 days of first inhaling from a cigarette [6].  
All published studies of the onset of nicotine dependence in the US have involved local 
convenience samples. The Centers for Disease Control published a brief report of a representative 
national survey that assessed six symptoms of diminished autonomy in youth, but the data were never 
analyzed to determine how many youth had one or more of symptoms [11]. This publication represents 
the first examination of the prevalence of symptoms in relation to the frequency of smoking in a 
national US sample.  
2. Methods  
The data for this analysis were obtained from the 1993 Teenage Attitudes and Practices Survey 
(TAPS-II), which was developed under the direction of the National Center for Health Statistics and 
the Office on Smoking and Health, Centers for Disease Control and Prevention[11-13]. Subjects in the 
TAPS-II survey were recruited from a probability sample of 5,590 persons aged 10-15 years, and 
9,135 respondents to the 1989 TAPS-I survey (aged 12-18 years). The TAPS-I sampling frame 
consisted of all persons aged 12-19 years who resided in households interviewed for the National 
Health Interview Survey (NHIS), an annual household interview survey of the non-institutionalized 
civilian population of the United States. The NHIS uses a multistage sampling design employing both 
clustering and stratification by race, sex and age [14]. Only the TAPS-I subjects who had been 
interviewed by phone were eligible for follow-up in TAPS-II. The TAPS-II survey was administered 
through telephone interviews, or if that was not possible, in person. 
The TAPS-II survey included six items that have subsequently been validated and used as indicators 
of diminished autonomy [9]. “I smoke because it is really hard to quit.” “How many times have you 
tried to quit smoking?” A prior attempt to quit smoking among current smokers was considered an 
indicator of diminished autonomy. “When you (quit/tried to quit) smoking did you ... feel a strong Int. J. Environ. Res. Public Health 2009, 6          
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need or urge to have a cigarette? ... feel more irritable? ... find it hard to concentrate? ... feel restless?” 
Response options were yes/no/don’t know/don’t remember, which we recoded as yes/no. We created 
dichotomous indicators of diminished autonomy (DA; any of the six symptoms including the four 
withdrawal symptoms versus none), and withdrawal symptoms (any of the four withdrawal symptoms 
versus none). Demographic data included age, gender, and race. Current smoking was defined as 
having smoked any cigarettes during the 30 days preceding the survey. Smoking variables (asked as 
continuous variables) included lifetime cigarettes smoked (which we grouped as <20, 20-99, and 100 
or more); the number of smoking days per month (grouped as 1-3 days, indicating less than weekly 
smoking; 4-29 days, indicating weekly but not daily smoking; and all 30, indicating daily smoking); 
and the number of cigarettes smoked per day (grouped as 0-4, 5-9, 10-14, and 15 or more). These 
groupings were chosen to allow for comparisons with other published studies. Only subjects who had 
smoked during the previous week were asked about the number of cigarettes smoked per day. 
Only current smokers were asked the six DA items; thus, our analyses were limited to that 
population. Further, only smokers who had failed at a quit attempt were asked about withdrawal 
symptoms. The CDC’s initial publication of the TAPS data therefore used the population of smokers 
who had failed to quit as the denominator for their prevalence estimates [11]. We felt that this inflated 
the prevalence estimates because the population was biased to include the most dependent individuals. 
For our analyses, we conservatively assumed that current smokers who had not been asked the 
withdrawal questions would have answered no to these items. The number of current smokers was the 
denominator for our prevalence estimates, which are about 30% lower than those published by the 
CDC [11].  
The brief report published by the CDC included only simple frequency distributions with no further 
analyses [11]. We used Chi-Square analysis to compare the prevalence of symptoms for subjects with 
different levels of tobacco use and gender. We performed a series of logistic regressions using the 
dichotomous outcome of any DA symptoms versus none, controlling for age, gender and race (white 
versus all others). Independent variables included daily use (no/yes), lifetime cigarette consumption 
(<20, 20-99, and ≥100 cigarettes), smoking days per month (<4, 4-29, and 30), and average daily 
cigarette consumption (<5, 5-9, 10-14, and ≥15 cigarettes). As the measures of tobacco use were 
correlated, each was entered into a separate regression because of multi-colinearity. Parallel 
regressions were performed with the dependent variable being withdrawal symptoms (‘any’ versus 
‘none’). 
Linear regressions were also performed with DA as a continuous measure (number of items 
endorsed, 0-6) while controlling for age, gender and race. Independent variables entered in separate 
runs included daily use (no/yes), and as continuous variables: lifetime cigarette consumption, smoking 
days per month, and average daily cigarette consumption. These regressions were repeated with 
withdrawal as a continuous variable (0-4 items endorsed) as the dependent variable. A p-value of 
<0.05 was used as a test of statistical significance. All analyses were weighted to provide estimates for 
a nationally representative population, and our analyses adjusted for both the clustering and stratified 
sampling design using SAS V9.1.3 (Proc SurveyReg and Proc SurveyLogistic; SAS Institute, Inc., 
Cary, NC). 
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3. Results and Discussion  
Of the probability sample of 5,590 individuals, 4,992 participated (89.3% response rate). Of the 
9,135 subjects followed up from TAPS-I, 7,960 (87.1%) participated in TAPS-II, for a total of 12,952 
subjects in TAPS-II. Of these, 51.2% were male and the mean age was 16.0 years (range 10-22, 
standard deviation 3.5). The sample is described in Table 1. Current smoking was reported by 2,091 
subjects (16.2%), of whom 52.9% were male and the mean age was 18.3 years (range 10-22). These 
subjects are the focus of the current analyses. Of the probability sample of 5,590 individuals, 4,992 
participated (89.3% response rate).  
Table 1. Sample characteristics. 
 n  % 
Gender 
Male 6636  51.2 
Female 6316  48.8 
Age 
10-14 4691  36.2 
15-17 3360  25.9 
18-19 2269  17.5 
20+ 2632  20.3 
Race 
White 10254  79.2 
Non-white 2698  20.8 
Smoking status among ever smokers 
Not a current smoker  2380  53.2 
Current smoker  2091  46.8 
Lifetime number of cigarettes smoked (smokers only) 
<20 1531  35.0 
20-99 849  19.4 
100+ 1996  45.6 
Days smoked in past 30 days (smokers only) 
0 2380  53.2 
1-3 384  8.6 
4-29 628  14.0 
30 1079  24.1 
Average number of cigarettes smoked per day (smokers 
only) 
0-4 575  34.5 
5-9 313  18.8 
10-14 310  18.6 
15+ 469  28.1 
 
All six DA symptoms were reported by 13.2% of current smokers; five by 12.4%; four by 10.3%; 
three by 8.8%; two by 8.7%; one by 17.6%; and none by 29.1%. Thus, 70.9% of current smokers had 
at least one symptom. All four withdrawal symptoms were reported by 15.8% of current smokers; Int. J. Environ. Res. Public Health 2009, 6          
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three by 12.8%; two by 11.2%; one by 10.4%; and none by 49.8%. Among 35 subjects who had 
smoked fewer than five cigarettes in their lifetime, 3 (9%) reported a withdrawal symptom, and 35% 
reported at least one of the six DA symptoms. 
Figure 1 and Table 2 present the proportion of current smokers who had DA or withdrawal 
symptoms in relation to gender and measures of tobacco use. Each symptom was present in subjects at 
the lowest level for each measure of tobacco use. Females had more symptoms than males. As 
expected, both DA and withdrawal increased in prevalence in relation to each measure of tobacco use. 
These relations persisted when controlled for age, gender and race, and when the outcome measure 
was treated as either a dichotomous or continuous variable (Tables 3 and 4). 
Table 2. The prevalence of symptoms of diminished autonomy in relation to gender and 
current and lifetime tobacco use. The cells indicate the percentage of subjects within each 
horizontal category reporting the symptom or symptoms listed at the head of each column. 
The Chi Square test comparing the prevalence of each symptom for the different categories 
within lifetime use, smoking days, cigarettes/day and gender were all significant at 
p<0.0001 (n=2,091).  
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Total population  70.9† 50.2  62.1 51.3 41.7 37.3 32.4 23.0 
Lifetime cigarette use 
1-19  (7.5%†) 29.8 12.6  24.9  6.8 4.9 7.8 5.5 5.4 
20-99  (14.2%) 42.5  22.4  42.0 13.9 15.3 14.0 9.4  7.1 
100+  (78.3%) 80.6  59.7  69.3 62.8 50.8 44.9 39.7 27.8 
Smoking days per month 
1-3  (18.9%) 37.5  15.9  32.5 10.3 9.8  9.8  8.7  5.3 
4-29  (29.8%) 65.6  47.2  59.7 40.9 36.3 29.7 28.5 18.1 
30  (51.3%)  86.5  64.9  73.9 72.4 56.9 52.1 43.6 32.6 
Cigarettes smoked per day 
0-4  (34.4%) 59.9  39.0  55.3 33.6 29.6 23.8 22.8 13.8 
5-9  (18.8%) 81.4  58.9  71.2 63.2 51.2 44.7 36.2 24.8 
10-14  (18.3%) 87.7  68.0  76.8 74.7 59.3 54.5 45.8 31.2 
15+  (28.5%) 90.2  68.9  76.1 78.8 61.0 56.2 49.8 38.7 
Gender 
Males  (51.2%) 68.9  48.3  60.0 51.2 40.2 34.6 30.8 21.2 
Females  (48.7%) 73.1  52.3  64.4 51.4 43.3 40.2 34.2 25.0 
†Percent of total population of current smokers. 
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Table 3. Relationship of diminished autonomy and tobacco withdrawal symptoms to four 
measures of tobacco use: logistic regression controlling for age, gender and race. 
  Diminished autonomy  Withdrawal 
  OR CI  OR  CI 
Ever smoked daily        
No 1.00    1.00   
Yes 7.04  5.63-8.81  6.63  5.26-8.35 
Lifetime cigarette use         
<20 1.00    1.00   
20-99 2.22  1.18-4.15  2.19  1.17-4.10 
100+ 12.42  6.87-22.45  12.01  6.68-21.61 
Smoking days per month       
<4 1.00    1.00   
4-29 4.98  3.52-7.03  4.89  3.47-6.88 
30 10.30  7.35-14.43  10.02  7.20-13.96 
Cigarettes smoked per day        
<5 1.00    1.00   
5-9 2.99  2.13-4.20  2.31  1.71-3.12 
10-14 4.93  3.32-7.34  3.45  2.47-4.82 
15+ 6.47  4.61-9.08  3.65  2.81-4.75 
Table 4. Association of diminished autonomy and tobacco withdrawal symptoms with four 
measures of tobacco use: linear regression controlling for age, gender and race. 
  Diminished autonomy  Withdrawal 
  β SE  p  β SE  p 
Ever smoked daily  2.14 .088  .0001  1.34  .062  .0001 
Cumulative lifetime cigarette use   0.03 .001  .0001  0.02  .001  .0001 
Smoking days per month  0.09 .003  .0001  0.05  .002  .0001 
Cigarettes smoked per day  0.08 .010  .0001  0.05  .007  .0001 
 
These data from a national sample of adolescents and young adults confirm that the earliest 
symptoms of diminished autonomy can appear after the first few cigarettes. Symptoms were reported 
by 35% of youth who had smoked fewer than five cigarettes. These data are in agreement with other 
recent studies. The Natural History of Nicotine Dependence (NDIT) study followed adolescents 
prospectively over five years to replicate the DANDY-1 study[15, 16]. More than a third of smokers 
had withdrawal symptoms prior to smoking four cigarettes. Kandel et al. evaluated new adolescent 
tobacco users for nicotine dependence symptoms using the American Psychiatric Association’s 
diagnostic criteria [7, 8, 17]. Thirty-five percent of the adolescents who experienced a symptom of 
dependence had done so within their first month of tobacco use, corresponding well to DANDY-2, in 
which 25% of those who had experienced symptoms of diminished autonomy did so within one month 
of initiating use [6]. A New Zealand national survey of almost 30,000 adolescent smokers reported that Int. J. Environ. Res. Public Health 2009, 6          
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27% of current smokers who had smoked only two cigarettes in their lifetime had symptoms of 
diminished autonomy as did 35% of those who had smoked 3-4 cigarettes [18]. A South African study 
of adolescents reported that almost half of youth who smoked less than one cigarette per week reported 
more than two Diagnostic and Statistical Manual nicotine withdrawal symptoms [19]. A 16-year 
longitudinal study in the US demonstrated that the trajectory to dependent adult smoking was set by 
the time youth were smoking two cigarettes per week [20]. Our study adds to a growing body of 
literature that indicates that approximately one-quarter to one-third of young smokers have early 
symptoms of emerging dependence by the time they have smoked five cigarettes. It should be 
emphasized that few of these individuals would have met the DSM case criteria for nicotine 
dependence.   
Figure 1. The percent of male and female current smokers reporting any symptom of 
diminished autonomy in relation to the number of smoking days per month.  
 
Particularly relevant for clinicians is the impact that the rapid onset of symptoms has for their 
patients: one-quarter of subjects who had not yet smoked 20 cigarettes reported having already failed 
an attempt to quit. Some symptoms were already present in 18.9% of subjects who were smoking less 
often than once per week, and in 29.8% of subjects who had not yet smoked 20 cigarettes. Although 
these figures may seem high, they likely underestimate the true prevalence of symptoms in this 
population. In the New Zealand study, 52% of youth who smoked less often than once per week had a 
symptom of diminished autonomy, as did 42% of subjects who had smoked fewer than 20 cigarettes in 
total[18]. The prevalence of symptoms we report here is low in comparison to those seen in all 
previous studies. This is likely attributable to a methodological limitation of the TAPS-II survey; both 
DANDY studies, the NDIT study and New Zealand study included 10 symptoms of diminished 
autonomy, but the TAPS-II survey included only six. Importantly, craving outside of a quit attempt Int. J. Environ. Res. Public Health 2009, 6          
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was not assessed, and this is the most common presenting symptom and the most prevalent symptom 
overall[5]. Also, the prevalence data reported here may be low because of our decision to assume that 
withdrawal symptoms were absent in current smokers who had never failed an attempt to quit 
smoking. For these reasons, the current study may underestimate the true prevalence of symptoms.  
Our data indicate that 16% of subjects who smoked less often than once per week reported 
withdrawal symptoms. These data likely underestimate the true prevalence of withdrawal symptoms in 
these very light smokers as only subjects who had tried to quit were asked the four withdrawal 
questions. Subjects who do not attempt to quit can still experience withdrawal symptoms between 
cigarettes and would have been missed.  
When DANDY-1 reported symptoms of emerging dependence after the first cigarette, the reliability 
of adolescent reports and the 10 HONC items used to assess diminished autonomy were questioned. 
As the six items used in the current study to assess diminished autonomy were later incorporated into 
the HONC, this reliability issue pertains to the current study as well. Conversely, evidence concerning 
the reliability of the HONC reflects on the reliability of the TAPS-II data. The HONC has 
demonstrated excellent internal consistency (α = 0.90 - 0.94) in three adolescent studies [9, 10, 21]. 
Endorsement of one or more HONC item was associated with an odds ratio of 195.8 for progression to 
daily smoking among subjects who had puffed on a cigarette, and with an odds ratio of 83 among 
those who had inhaled [6]. The strong predictive power and high internal consistency of the HONC [9, 
10, 21], its very good test-retest reliability [10], its stable single-factor structure [10], its ability to 
predict long-term smoking cessation outcomes [6], and its external validity as demonstrated by 
associations in the expected directions with lifetime maximum cigarette consumption [5], current 
smoking days per month [10], daily cigarette consumption [10], greatest length of abstinence, use of 
pharmacological cessation aids, the modified Fagerström Tolerance Questionnaire and the Fagerström 
Test of Nicotine Dependence [21-23] are individually, and collectively, incompatible with the 
hypothesis that adolescents are misreporting symptoms. The dose-response relationship observed 
between the prevalence of diminished autonomy and each of three measures of tobacco use in the 
current study provides additional reassurance that symptom reports are reliable.  
By documenting the appearance of withdrawal symptoms in youth who have smoked only a few 
cigarettes, this study adds to the accumulating evidence [4, 6, 16, 18, 19] that contradicts the 
assumption that nicotine withdrawal is the product of chronic moderate daily use, or that the 
development of withdrawal symptoms requires a person to smoke at least five cigarettes per day to 
remain comfortable. As demonstrated by the data in this study, withdrawal symptoms can appear while 
cigarettes are spaced more than a week apart. Adolescents describe how withdrawal symptoms can be 
initially kept at bay for a week or more by smoking a single cigarette. But over time, the duration of 
relief obtained from each cigarette shortens progressively and youths must space their cigarettes at 
ever closer intervals to suppress withdrawal [24].  
Do novice smokers experience withdrawal the same as adult smokers? When youth report difficulty 
concentrating, are they experiencing the same thing as an adult who reports difficulty concentrating? 
(One might also question whether two adult smokers are having the same experience.) The relevant 
question is not whether youths’ symptoms are identical to those of adults, but whether adolescent 
symptoms affect the trajectory of smoking. They do, the appearance of symptoms increases the risk of Int. J. Environ. Res. Public Health 2009, 6          
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progressing to daily smoking by nearly 200-fold [6]. Whatever it is that youth are experiencing when 
they report symptoms after smoking one or two cigarettes, it has great clinical relevance. 
Strengths of this study include the relatively large nationally representative sample, high 
participation rate, wide age range, racially mixed population, and the use of the diminished autonomy 
measure that allows us to compare this dataset to those from the two DANDY studies, NDIT and the 
New Zealand national survey which all used this metric. This report adds to the previous brief report of 
this dataset by (1) using all smokers as the denominator, (2) calculating the percentage of subjects who 
had one or more symptoms of diminished autonomy to determine the proportion of youth who are 
affected at each level of tobacco use, and (3) including logistic and linear regression analyses to 
determine the impact of gender, current use, and lifetime tobacco use on the emergence of diminished 
autonomy and withdrawal symptoms. Limitations include the use of only six symptoms of diminished 
autonomy. Nicotine dependence as defined by the DSM was not assessed, although the symptoms we 
evaluated are considered symptoms of nicotine dependence according to the DSM criteria[7]. We 
relied on symptom self-reports as the symptoms of nicotine dependence are largely subjective. A 
recent study demonstrates that nicotine dependence symptom reports by adolescents cannot be 
attributed to false reporting based on expectations [25]. Although the data were collected a number of 
years ago, the relationship between tobacco use and symptom development would not have changed. 
4. Conclusions  
This national study adds to the mounting evidence that symptoms of diminished autonomy, 
including those of nicotine withdrawal, can appear after the first few cigarettes, and appear commonly 
in youth who are non-daily smokers. 
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